Q4 2025 earnings call recap: pemvidutide Phase III MASH plans, Phase II data, FDA status, cash runway to 2028—read now.

Phase 1/2a Clinical Study 36 Month Results Featured at Clinical Trials at the Summit 2025Achieved First Milestone Under Worldwide Collaboration with Genentech Based on RG6501 (OpRegen Cell Therapy) ...

When England were forced by the Government to cancel the tour arranged for South Africa to the United Kingdom in 1970 the authorities at Lord's through the Test and County Cricket Board devised a seri ...

There’s a restaurant in Linthicum Heights that doesn’t need a waterfront location or fancy decor to prove it serves ...

Q4 2025 earnings call: cash runway to Q2 2028, OpRegen site expansion, AlloSCOPE progress—read key takeaways now.

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industr ...

The results include a comparison between two different basis functions for temporal selectivity and how these generate different predictions for the dynamics of neural populations. The conclusions are ...

War in the Middle East is again drving the narrative, with US$6000/oz gold now on the agenda for analysts as ... Read More The post Gold Digger: Drums of war have gold bugs calling for US$6000 ...

There have been a lot of great basketball players to have come through the Pentucket girls program over the last couple of ...

From the iconic sounds to the spectacle of seeing thousands of greater sandhill cranes taking flight, the Monte Vista Crane ...